Medical Oncology

Neoadjuvant chemotherapy with ifosfamide and cisplatin combination in advanced head and neck cancer: A retrospective analysis of 519 patients: A single institution experience
pp. 1-5(5)
Authors: Pai, V.; Mazumdar, A.; Deshmukh, C.; Bakshi, A.; Parikh, D.; Parikh, P.; Mistry, R.; Pathak, K.

Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors
pp. 7-12(6)
Authors: Masters, Gregory; Brockstein, Bruce; Mani, Sridhar; Ratain, Mark

Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy
pp. 13-17(5)
Authors: Avilés, Agustin; Neri, Natividad; Fernández, Raúl; Calva, Angel; Huerta-Guzmán, Judith; Nambo, M.

Docetaxel and vinorelbine: An effective regimen in recurrent squamous cell esophageal carcinoma
pp. 19-24(6)
Authors: Airoldi, Mario; Cortesina, Giorgio; Giordano, Carlo; Pedani, Fulvia; Bumma, Cesare; Gabriele, Pietro

Liver metastasis at the time of initial diagnosis of lung cancer
pp. 25-28(4)
Authors: Kagohashi, Katsunori; Satoh, Hiroaki; Ishikawa, Hiroichi; Ohtsuka, Morio; Sekizawa, Kiyohisa

Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxol
pp. 29-35(7)
Authors: Rubenstein, Marvin; Slobodskoy, Leonid; Mirochnik, Yelena; Guinan, Patrick

Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer
pp. 37-43(7)
Authors: Cassinello, J.; López-Alvarez, P.; Martínez-Guisado, A.; Valladares, M.; Huidobro, G.; López, R.; Bohn, U.; Sevilla, I.; Ballesteros, P.; Jorge, M.; Pérez-Carrión, R.; Fernández, J.; Dorta, J.

Serum markers variation consistent with autoschizis induced by ascrobic acid-menadione in patients with prostate cancer
pp. 45-52(8)
Authors: Lasalvia-Prisco, Eduardo; Cucchi, Silvia; Vázquez, Jesús; Lasalvia-Galante, Eduardo; Golomar, Wilson; Gordon, William

Phase I trial of fludarabine and paclitaxel in non-hodgkin's lymphoma
pp. 53-58(6)
Authors: Abbasi, Muhammad; Sparano, Joseph; Sarta, Catherine; Wiernik, Peter

Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors
pp. 59-67(9)
Authors: Fjällskog, Marie-Louise; Ludvigsen, Eva; Stridsberg, Mats; Öberg, Kjell; Eriksson, Barbro; Janson, Eva

Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-α administration
pp. 69-76(8)
Authors: Hájek, Roman; Zácková, Daniela; Büchler, Tomás; Penka, Miroslav; Krahulcová, Eva; Korśstek, Zdenek; Vinklárková, Jaroslava; Adler, Jirí; Janovská, Eva; Indrák, Karel; Faber, Edgar; Doubek, Michal; Klabusay, Martin; Oltová, Alexandra; Kuglík, Petr; Bourková, Ludmila; Dusek, Ladislav; Mareschová, Iveta; Mayer, Jirí; Vorlícek, Jirí

Quantitation of cyclin D1 over-expression using competitive fluorescent reverse transcription polymerase chain reaction: A tool for the differential diagnosis of mantle cell lymphoma
pp. 77-85(9)
Authors: Wickham, C.; Armitage, H.; Joyner, M.; Sarsfield, P.; Boyce, M.; Wilkins, B.; Jones, D.; Ellard, S.

Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma
pp. 87-93(7)
Authors: Spano, J.; Soria, J.; Kambouchner, M.; Piperno-Neuman, S.; Morin, F.; Morere, J.; Martin, A.; Breau, J.